European Primary Care Cardiovascular Society
EPCCS 2019 Slides prepared and presented by prof. Richard Hobbs (Oxford, United Kingdom), here offered as an educational service.
A prospective, accelerometer-based study shows that total sedentary time and the pattern in which it accumulates (long bouts vs interrupted) are positively associated with the risk of CVD in older women.
Large population-based study with 10 years follow-up showed that frequent tooth brushing and regular dental visits lower the risk of CV events associated with oral health problems.
Learn more about the activities of EPCCS that are aimed at supporting primary care professionals manage their patients with cardiovascular and cardiometabolic disease.
A meta-analysis including recent trials and data of over 157.000 individuals shows no benefit of aspirin for primary CV prevention, and a higher risk of major bleeding and intracranial hemorrhage
Prof. Hobbs stresses the importance of CVRM in primary care and how to manage this risk beyond glucose control.
The UMC Utrecht's Center for Circulatory Health has developed algorithms with which the risk of CVD and the effect of medication to reduce this risk, can be predicted for every adult. Use of the risk calculators is free.
ESC 2018 The PURE cohort study showed reduced risk of CV disease and mortality with high-quality diets in general populations worldwide.
EPCCS 2018 Three professors discuss how best to measure blood pressure, when to call it hypertension, and once hypertension is diagnosed, what BP target to aim for, based on the latest scientific insights.
This summary of the presentation by prof. Hobbs illustrates why diabetes poses a high burden to primary health care, since patients with T2DM are at high CV risk. This risk can be lowered by targeting various risk factors.
Prof. Grobbee discusses how to reduce CV risk in patients with T2DM, considering the effects of glucose control and the effect of newer agents
ADA 2018 In long-term Danish Steno 2 study, interventions targeting complications were found to improve disease-free-life length, and costs were not higher than with conventional treatment.
